fluorescein-5-isothiocyanate and ciglitazone

fluorescein-5-isothiocyanate has been researched along with ciglitazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Ge, J; Huang, D; Jia, Q; Liang, C; Luo, Y; Wang, K; Wu, Z; Xu, C	1

Other Studies

1 other study(ies) available for fluorescein-5-isothiocyanate and ciglitazone

Article	Year
Ciglitazone inhibits oxidized-low density lipoprotein induced immune maturation of dendritic cells. Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:3 Topics: Antigens, CD; Antigens, CD1; B7-2 Antigen; CD40 Antigens; Dendritic Cells; Dextrans; Endocytosis; Flow Cytometry; Fluorescein-5-isothiocyanate; HLA-DR Antigens; Humans; Immunity, Cellular; Immunophenotyping; Interleukin-10; Interleukin-12; Lipopolysaccharide Receptors; Lipopolysaccharides; Lipoproteins, LDL; Membrane Glycoproteins; Monocytes; PPAR gamma; Thiazolidinediones; Tumor Necrosis Factor-alpha	2004

Article

Year

Ciglitazone inhibits oxidized-low density lipoprotein induced immune maturation of dendritic cells.

Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:3

Topics: Antigens, CD; Antigens, CD1; B7-2 Antigen; CD40 Antigens; Dendritic Cells; Dextrans; Endocytosis; Flow Cytometry; Fluorescein-5-isothiocyanate; HLA-DR Antigens; Humans; Immunity, Cellular; Immunophenotyping; Interleukin-10; Interleukin-12; Lipopolysaccharide Receptors; Lipopolysaccharides; Lipoproteins, LDL; Membrane Glycoproteins; Monocytes; PPAR gamma; Thiazolidinediones; Tumor Necrosis Factor-alpha

2004